-
1
-
-
0023936377
-
-
Amato MP, Fratiglioni L, Groppi C, Siracusa G, Amaducci L (1988) Interrater reliability in assessing functional systems and disability on the Kurtzke scale in multiple sclerosis. Arch Neurol 45:746-748
-
(1988)
Arch Neurol
, vol.45
, pp. 746
-
-
Amato1
-
2
-
-
0034986367
-
-
Bethoux F, Miller DM, Kinkel RP (2001) Recovery following acute exacerbations of multiple sclerosis: from impairment to quality of life. Mult Scler 7:137-142
-
(2001)
Mult Scler
, vol.7
, pp. 137
-
-
Bethoux1
-
3
-
-
0034992601
-
-
Bjartmar C, Trapp BD (2001) Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences. Curr Opin Neurol 14:271-278
-
(2001)
Curr Opin Neurol
, vol.14
, pp. 271
-
-
Bjartmar1
-
4
-
-
0025817469
-
-
Bornstein MB, Miller A, Slagle S, Weitzman M, Drexler E, Keilson M, Spada V, Weiss W, Appel S, Rolak L, et al. (1991) A placebo-controlled, double-blind, randomized, two- center, pilot trial of Cop 1 in chronic progressive multiple sclerosis. Neurology 41:533-539
-
(1991)
Neurology
, vol.41
, pp. 533
-
-
Bornstein1
-
5
-
-
0037029424
-
-
Compston A, Coles A (2002) Multiple sclerosis. Lancet 359:1221-1231
-
(2002)
Lancet
, vol.359
, pp. 1221
-
-
Compston1
-
6
-
-
33644628396
-
-
Confavreux C, Vukusic S (2006) Accumulation of irreversible disability in multiple sclerosis: from epidemiology to treatment. Clin Neurol Neurosurg 108:327-332
-
(2006)
Clin Neurol Neurosurg
, vol.108
, pp. 327
-
-
Confavreux1
-
7
-
-
0037379402
-
-
Confavreux C, Vukusic S, Adeleine P (2003) Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 126:770-782
-
(2003)
Brain
, vol.126
, pp. 770
-
-
Confavreux1
-
8
-
-
0022633684
-
-
Durelli L, Cocito D, Riccio A, Barile C, Bergamasco B, Baggio GF, Perla F, Delsedime M, Gusmaroli G, Bergamini L (1986) High-dose intravenous methyl prednisolone in the treatment of multiple sclerosis: clinical-immunologic correlations. Neurology 36:238-243
-
(1986)
Neurology
, vol.36
, pp. 238
-
-
Durelli1
-
9
-
-
0037983828
-
-
Eriksson M, Andersen O, Runmarker B (2003) Long-term follow up of patients with clinically isolated syndromes, relapsing- remitting and secondary progressive multiple sclerosis. Mult Scler 9:260-274
-
(2003)
Mult Scler
, vol.9
, pp. 260
-
-
Eriksson1
-
10
-
-
0014902840
-
-
Fog T, Linnemann F (1970) The course of multiple sclerosis in 73 cases with computer-designed curves. Acta Neurol Scand 47(Suppl):3-175
-
(1970)
Acta Neurol Scand
, vol.47
, pp. 3
-
-
Fog1
-
11
-
-
0027418515
-
-
IFNB Multiple Sclerosis Study Group (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43:655-661
-
(1993)
Neurology
, vol.43
, pp. 655
-
-
Ifnb1
-
12
-
-
0034727059
-
-
Jacobs LD, Beck RW, Simon JH, Kinkel RP, Brownscheidle CM, Murray TJ, Simonian NA, Slasor PJ, Sandrock AW (2000) Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. N Engl J Med 343:898-904
-
(2000)
N Engl J Med
, vol.343
, pp. 898
-
-
Jacobs1
-
13
-
-
0031750982
-
-
Kantarci O, Siva A, Eraksoy M, Karabudak R, Sutlas N, Agaoglu J, Turan F, Ozmenoglu M, Togrul E, Demirkiran M (1998) Survival and predictors of disability in Turkish MS patients. Turkish Multiple Sclerosis Study Group (TUMSSG). Neurology 51:765-772
-
(1998)
Neurology
, vol.51
, pp. 765
-
-
Kantarci1
-
14
-
-
0017662649
-
-
Kurtzke JF, Beebe GW, Nagler B, Kurland LT, Auth TL (1977) Studies on the natural history of multiple sclerosis - 8. Early prognostic features of the later course of the illness. J Chronic Dis 30:819-830
-
(1977)
J Chronic Dis
, vol.30
, pp. 819
-
-
Kurtzke1
-
15
-
-
0344738667
-
-
Lublin FD, Baier M, Cutter G (2003) Effect of relapses on development of residual deficit in multiple sclerosis. Neurology 61:1528-1532
-
(2003)
Neurology
, vol.61
, pp. 1528
-
-
Lublin1
-
16
-
-
0034955141
-
-
McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121-127
-
(2001)
Ann Neurol
, vol.50
, pp. 121
-
-
McDonald, W.I.1
Compston, A.2
Edan, G.3
Goodkin, D.4
Hartung, H.P.5
Lublin, F.D.6
McFarland, H.F.7
Paty, D.W.8
Polman, C.H.9
Reingold, S.C.10
Sandberg-Wollheim, M.11
Sibley, W.12
Thompson, A.13
Van Den Noort, S.14
Weinshenker, B.Y.15
Wolinsky, J.S.16
-
17
-
-
8044242916
-
-
Millefiorini E, Gasperini C, Pozzilli C, D'Andrea F, Bastianello S, Trojano M, Morino S, Morra VB, Bozzao A, Calo A, Bernini ML, Gambi D, Prencipe M (1997) Randomized placebo-controlled trial of mitoxantrone in relapsing- remitting multiple sclerosis: 24- month clinical and MRI outcome. J Neurol 244:153-159
-
(1997)
J Neurol
, vol.244
, pp. 153
-
-
Millefiorini1
-
18
-
-
4344571037
-
-
Nos C, Sastre-Garriga J, Borras C, Rio J, Tintore M, Montalban X (2004) Clinical impact of intravenous methylprednisolone in attacks of multiple sclerosis. Mult Scler 10:413-416
-
(2004)
Mult Scler
, vol.10
, pp. 413
-
-
Nos1
-
19
-
-
0025314243
-
-
Noseworthy JH, Vandervoort MK, Wong CJ, Ebers GC (1990) Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group. Neurology 40:971-975
-
(1990)
Neurology
, vol.40
, pp. 971
-
-
Noseworthy1
-
20
-
-
2942589194
-
-
O'Connor PW, Goodman A, Willmer- Hulme AJ, Libonati MA, Metz L, Murray RS, Sheremata WA, Vollmer TL, Stone LA (2004) Randomized multicenter trial of natalizumab in acute MS relapses: clinical and MRI effects. Neurology 62:2038-2043
-
(2004)
Neurology
, vol.62
, pp. 2038
-
-
O'Connor1
-
21
-
-
0842305095
-
-
Ozakbas S, Cagiran I, Ormeci B, Idiman E (2004) Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis. J Neurol Sci 218:3-7
-
(2004)
J Neurol Sci
, vol.218
, pp. 3
-
-
Ozakbas1
-
22
-
-
0014458409
-
-
Panelius M (1969) Studies on epidemiological, clinical and etiological aspects of multiple sclerosis. Acta Neurol Scand:Suppl 39:31-82
-
(1969)
Acta Neurol Scand:Suppl
, vol.39
, pp. 31
-
-
Panelius1
-
23
-
-
0036196863
-
-
Patzold T, Schwengelbeck M, Ossege LM, Malin JP, Sindern E (2002) Changes of the MS functional composite and EDSS during and after treatment of relapses with methylprednisolone in patients with multiple sclerosis. Acta Neurol Scand 105:164-168
-
(2002)
Acta Neurol Scand
, vol.105
, pp. 164
-
-
Patzold1
-
24
-
-
0019967543
-
-
Patzold U, Pocklington PR (1982) Course of multiple sclerosis. First results of a prospective study carried out of 102 MS patients from 1976-1980. Acta Neurol Scand 65:248-266
-
(1982)
Acta Neurol Scand
, vol.65
, pp. 248
-
-
Patzold1
-
25
-
-
0020686503
-
-
Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227-231
-
(1983)
Ann Neurol
, vol.13
, pp. 227
-
-
Poser1
-
26
-
-
0345601517
-
-
PRISMS Study Group (1998) Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. Lancet 352:1498-1504
-
(1998)
Lancet
, vol.352
, pp. 1498
-
-
Prisms1
-
27
-
-
76549217481
-
-
Schumacker GA, Beebe G, Kibler RF, Kurland LT, Kurtzke JF, McDowell F, Nagler B, Sibley WA, Tourtellotte WW, Willmon TL (1965) Problems of experimental trials of therapy in multiple sclerosis: report by the Panel On the Evaluation of Experimental Trials of Therapy in Multiple Sclerosis. Ann N Y Acad Sci 122:552-568
-
(1965)
Ann N Y Acad Sci
, vol.122
, pp. 552
-
-
Schumacker1
-
28
-
-
0033615464
-
-
Smith KJ, McDonald WI (1999) The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease. Philos Trans R Soc Lond B Biol Sci 354:1649-1673
-
(1999)
Philos Trans R Soc Lond B Biol Sci
, vol.354
, pp. 1649
-
-
Smith1
-
29
-
-
33751180140
-
-
Waxman SG (2006) Axonal conduction and injury in multiple sclerosis: the role of sodium channels. Nat Rev Neurosci 7:932-941
-
(2006)
Nat Rev Neurosci
, vol.7
, pp. 932
-
-
Waxman1
-
30
-
-
0024796845
-
-
Weinshenker BG, Bass B, Rice GP, Noseworthy J, Carriere W, Baskerville J, Ebers GC (1989) The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course. Brain 112(Pt 6):1419-1428
-
(1989)
Brain
, vol.112
, pp. 1419
-
-
Weinshenker1
-
31
-
-
33748681140
-
-
West T, Wyatt M, High A, Bostrom A, Waubant E (2006) Are initial demyelinating event recovery and time to second event under differential control? Neurology 67:809-813
-
(2006)
Neurology
, vol.67
, pp. 809
-
-
West1
|